Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-14

Clinical Trial Update: C-Type Natriuretic Peptide and Achondroplasia

View source ↗

Summary

This update reports the completion of a clinical trial investigating C-type natriuretic peptide for achondroplasia and hypochondroplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • C-type Natriuretic Peptide (C-type natriuretic peptide)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Achondroplasia, Hypochondroplasia | Status: COMPLETED